Brief: Unity Biotechnology Reports Q1 2022 Results
10/05/2022 21:53
May 10 (Reuters) - UNITY Biotechnology Inc UBX.O :
* UNITY BIOTECHNOLOGY, INC. REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS UPDATES
* BELIEVES THAT CURRENT CASH, CASH EQUIVALENTS, AND
MARKETABLE
SECURITIES ARE SUFFICIENT TO FUND OPERATIONS THROUGH Q1 OF 2023
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.28
* Q1 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1KljWL
Further company coverage: UBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force